Should Consumers Trust Online Reviews?

Bringing together leaders, lawmakers and lawbreakers. Host Luke Fox explores how innovations in business and technology are redefining our trust in security measures.

Product reviews are essential in eCommerce, but how many of them are actually real? Fake reviews are a massive problem in the industry, but one website seeks to deliver transparency and accuracy on Amazon. The Trust Revolution host Luke Fox spoke with Tommy Noonan, founder of ReviewMeta. The website analyzes Amazon reviews and estimates which reviews to trust.

Noonan’s journey to ReviewMeta started in college when his roommate had bad side effects for a fitness supplement. Noonan scoured the web looking for reviews and didn’t find any.
“People need a trusted source of supplement reviews from consumers, rather than relying on what’s on the label. So I created a site for supplement reviews to bring this transparency, and it took off.”

It became a trusted source for millions but also noticed shady reviews. “Brands wanted to pretend to be consumers to write fake reviews. I began to research these suspicious reviews and removing them,” Noonan said.

Noonan soon learned that Amazon reviews were ripe with falsehoods. He then went through 580 reviews on one product as an analysis. Then he began writing a program to automate this, scraping the content from the reviews and analyzing them based on 15 different tests. That became ReviewMeta.

 

“We look for suspicious traits like unverified purchases and others and flag those. The program throws out anything that fails the tests. Then we recalculate the average rating and show that on our site.”

 

In the beginning, Noonan assumed that Amazon would fix the fake review situation. “I moved forward anyway, thinking the site would be obsolete. Instead, five years later, Amazon is getting worse, not better,” he added.

Amazon’s singular focus on revenue means tracing fake reviews isn’t a priority. They are to ReviewMeta, as they want to deliver accurate, honest information to consumers.

 

Catch Up On Previous Episodes of The Trust Revolution!

 

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

 

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More